Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas MacDonald

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
Journal of Medicinal Chemistry|September 15, 2023
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's DiseaseLongbin Liu, Karine Malagu, Alan F Haughan, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
Journal of Medicinal Chemistry|September 15, 2023
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's DiseaseLongbin Liu, Karine Malagu, Alan F Haughan, et al.
Pageof 9